Juan W. Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, shared a post on LinkedIn:
“In complex cancers like cholangiocarcinoma, clinical decisions are rarely simple.
As treatment strategies evolve with immunotherapy, targeted therapy, biomarker-driven approaches, and radiation integration, clinicians must translate emerging evidence into meaningful, patient-centered decisions.
Please join the Horizon IV – Advancing Conversations in Precision Oncology
An academic initiative by Jarurat Care Foundation focused on strengthening oncology education and collaborative learning.
This virtual forum brings together leading global and Indian experts to examine data and apply it to real-world clinical practice critically.
Supported by leading institutions:
- MD Anderson Cancer Center
- Sir H.N. Reliance Foundation Hospital & Research Centre
- ILBS India
- Cholangiocarcinoma Foundation
Speakers:
I will be joining Eugene Koay for this discussion
Co-Chairs & Speakers
- Milind Javle
- Sewanti Limaye, MBBS, MD, MS
- Dr. Shailesh Talati
- Dr. Deepti Sharma
- Nikhil Himthani
28 February 2026
7:30 PM – 9:00 PM (IST)
Online | Zoom
Register here.”
Other OncoDaily articles featuring Juan W. Valle.